chr16-1229737-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_024164.6(TPSB2):​c.62C>T​(p.Ala21Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000635 in 1,575,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000041 ( 0 hom., cov: 23)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

TPSB2
NM_024164.6 missense, splice_region

Scores

3
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.369
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.090507954).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TPSB2NM_024164.6 linkuse as main transcriptc.62C>T p.Ala21Val missense_variant, splice_region_variant 3/6 ENST00000606293.5 NP_077078.5 P20231A0A140VJT7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TPSB2ENST00000606293.5 linkuse as main transcriptc.62C>T p.Ala21Val missense_variant, splice_region_variant 3/61 NM_024164.6 ENSP00000482743.1 P20231
TPSB2ENST00000612142.1 linkuse as main transcriptc.83C>T p.Ala28Val missense_variant, splice_region_variant 2/51 ENSP00000478695.1 A0A087WUI4
TPSB2ENST00000611196.4 linkuse as main transcriptn.62C>T splice_region_variant, non_coding_transcript_exon_variant 3/81 ENSP00000484461.1 A0A087X1U0

Frequencies

GnomAD3 genomes
AF:
0.0000407
AC:
6
AN:
147444
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000156
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000144
AC:
3
AN:
207820
Hom.:
0
AF XY:
0.00000884
AC XY:
1
AN XY:
113182
show subpopulations
Gnomad AFR exome
AF:
0.000145
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000104
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000280
AC:
4
AN:
1427800
Hom.:
0
Cov.:
44
AF XY:
0.00000141
AC XY:
1
AN XY:
708586
show subpopulations
Gnomad4 AFR exome
AF:
0.0000630
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.11e-7
Gnomad4 OTH exome
AF:
0.0000170
GnomAD4 genome
AF:
0.0000407
AC:
6
AN:
147444
Hom.:
0
Cov.:
23
AF XY:
0.0000417
AC XY:
3
AN XY:
71894
show subpopulations
Gnomad4 AFR
AF:
0.000156
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000453
ExAC
AF:
0.0000249
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 14, 2024The c.62C>T (p.A21V) alteration is located in exon 3 (coding exon 2) of the TPSB2 gene. This alteration results from a C to T substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.018
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
15
DANN
Benign
0.92
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.55
T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.091
T;T
MetaSVM
Benign
-0.96
T
PrimateAI
Uncertain
0.66
T
Sift4G
Benign
0.34
T;T
Vest4
0.25
MVP
0.14
ClinPred
0.13
T
GERP RS
-0.52
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750434330; hg19: chr16-1279738; API